Cargando…

Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death

INTRODUCTION: It is uncertain if plasma HIV-1 tropism is an independent predictor of short-term risk of clinical progression / death, in addition to the CD4 count and HIV RNA level. We conducted a nested case-control study within EuroSIDA to assess this question amongst people with current HIV RNA l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casadellà Fontdevila, Maria, Cozzi-Lepri, Alessandro, Phillips, Andrew, Noguera Julian, Marc, Bickel, Marcus, Sedlacek, Dalibor, Kronborg, Gitte, Lazzarin, Adriano, Zilmer, Kai, Clotet, Bonaventura, Lundgren, Jens D, Paredes, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P153
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225412/ https://www.ncbi.nlm.nih.gov/pubmed/25397435 http://dx.doi.org/10.7448/IAS.17.4.19685

Ejemplares similares

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death
por: Casadellà, Maria, et al.
Publicado: (2017)

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO
por: Molina, Jean-Michel, et al.
Publicado: (2014)

Changes in hospitalizations due to opportunistic infections, chronic conditions and other causes among HIV patients (1989–2011). A study in a HIV unit
por: Redondo Sanchez, C, et al.
Publicado: (2012)

Ageing and ethical challenges in physiotherapy: application of the RIPS model in ethical decision-making
por: Sousa, José Luís, et al.
Publicado: (2021)

PROFILAXIA PÓS-EXPOSIÇÃO (PEP) DE RISCO À INFECÇÃO PELO VÍRUS DA IMUNODEFICIÊNCIA HUMANA (HIV) EM TEMPOS DE COVID-19: UM ESTUDO COMPARATIVO
por: Prates, Marcus Vinicius Camargo, et al.
Publicado: (2022)

Un cas de pemphigoïde p200 après une vaccination contre la COVID-19
por: Bailly-Caille, B., et al.
Publicado: (2022)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC
por: Ramón Santos, José, et al.
Publicado: (2014)

Implementing a SARS-CoV-2 Early Warning System in Valencia (Spain) and its Correlation with Epidemiological Indicators
por: Perez, P., et al.
Publicado: (2022)

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression
por: Llibre, Josep M, et al.
Publicado: (2014)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014)

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner
por: Echeverría, Patricia, et al.
Publicado: (2014)

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

Temporal increase in HIV-1 non-R5 tropism frequency among antiretroviral-naive patients from northern Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTI
por: Di Yacovo, Silvana, et al.
Publicado: (2014)

Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohort
por: Cingolani, Antonella, et al.
Publicado: (2014)

Stable HIV-1 integrase diversity during initial HIV-1 RNA Decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy
por: Noguera-Julian, Marc, et al.
Publicado: (2013)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Predictors of lack of serological response to syphilis treatment in HIV-infected subjects
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort
por: Di Biagio, Antonio, et al.
Publicado: (2014)

Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
por: Carbone, Alessia, et al.
Publicado: (2014)

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
por: Gianotti, Nicola, et al.
Publicado: (2014)

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

Research on demands and accessibility of health services for AIDS long-surviving patients with AIDS-nonrelated diseases: a survey in central China
por: He, Na, et al.
Publicado: (2014)

Analysis of causes of death among HIV-infected patients of Kiev Regional AIDS Center during 2013
por: Stepchenkova, Tetiana, et al.
Publicado: (2014)

HIV/AIDS mortality in a south east European country versus a west European country
por: Dragovic, Gordana, et al.
Publicado: (2014)

Proton 1H- and Phosphorus 31P-MR spectroscopy (MRS) in asymptomatic HIV-positive patients
por: Schuettfort, Gundolf, et al.
Publicado: (2014)

Improving HIV-1 tropism determination by combining geno2pheno and V3 net charge calculation
por: Montagna, C, et al.
Publicado: (2012)

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis
por: Ammassari, A, et al.
Publicado: (2012)

Prevalence and concordance of high cardiovascular disease scores in HIV/AIDS patients from Croatia and Serbia with four international algorithms
por: Begovac, Josip, et al.
Publicado: (2014)

HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization
por: Pou, Christian, et al.
Publicado: (2013)

AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)

Prevalence and European AIDS Clinical Society (EACS) criteria evaluation for proximal renal tubular dysfunction diagnosis in patients under antiretroviral therapy in routine setting
por: Pitisci, Lorenzo, et al.
Publicado: (2014)

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults
por: Gatell, Josép M, et al.
Publicado: (2014)

Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population
por: Thorsteinsson, Kristina, et al.
Publicado: (2014)

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jl0c6uq9qc47jv6pgoamloqr4p